---
category: listing
circular_id: bec45f7f24ccce08
date: '2025-12-23'
description: Application for trading of 24,42,000 equity shares issued on preferential
  basis at Rs. 42.25 per share, with allotment dates on October 1st and 3rd, 2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={0E454ADD-819B-4FCB-B343-C0E731365990}&noticeno=20251223-10&dt=12/23/2025&icount=10&totcount=48&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine preferential allotment listing for a single company with standard
  lock-in periods; limited market-wide impact
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251223-10&attachedId=25c06983-b36b-4210-ba75-fefd170035a9
processing:
  attempts: 1
  content_hash: dcb2095e41804d0b
  processed_at: '2025-12-23T18:54:13.535915'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-23T10:32:43+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={0E454ADD-819B-4FCB-B343-C0E731365990}&noticeno=20251223-10&dt=12/23/2025&icount=10&totcount=48&flag=0
severity: low
source: bse
stocks:
- SHELTERPHARMA
tags:
- listing
- preferential-allotment
- equity-shares
- new-securities
- shelter-pharma
- lock-in
title: Listing of New Securities of Shelter Pharma Limited - Preferential Allotment
---

## Summary

Shelter Pharma Limited has applied to BSE for trading approval of 24,42,000 equity shares of face value Rs. 10 per share, issued on a preferential basis at Rs. 42.25 per share (including premium of Rs. 32.25). The allotment was completed in two tranches on October 1st and October 3rd, 2025, with distinctive numbers ranging from 1,15,59,793 to 1,40,01,792.

## Key Points

- Total equity shares issued: 24,42,000
- Face value: Rs. 10 per share
- Issue price: Rs. 42.25 per share (premium: Rs. 32.25)
- Allotment dates: October 1, 2025 and October 3, 2025
- Lock-in periods: June 29-30, 2026 and June 30, 2027
- Distinctive number range: 1,15,59,793 to 1,40,01,792
- Managing Director: Mustaqim Nisarahmed Sabugar (DIN: 01456841)

## Regulatory Changes

No regulatory changes introduced. This is a standard preferential allotment listing application.

## Compliance Requirements

- Shares subject to lock-in until specified dates (June 2026 and June 2027)
- List of allottees provided as per BSE requirements
- Distinctive numbers assigned to track allotted shares

## Important Dates

- **Allotment Date 1**: October 1, 2025
- **Allotment Date 2**: October 3, 2025
- **Lock-in expiry dates**: June 29-30, 2026 (for most allottees); June 30, 2027 (for remaining allottees)
- **Circular date**: December 23, 2025

## Impact Assessment

Limited market impact as this is a company-specific preferential allotment. The lock-in periods ensure allottees cannot immediately sell shares, providing stability. The preferential issue increases Shelter Pharma's equity base and provides capital infusion to the company. No immediate trading impact expected for broader market participants.